CONMED Corporation
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.2% | -20.5% | +71.5% | +13.9% | +27.4% | -32.2% | +73.2% | -70.1% | +275.7% | +33.2% | +2.2% | |
| – | -4.1% | +26.0% | +5.9% | +5.6% | +17.0% | +0.4% | -2.6% | -1.7% | -26.1% | -0.2% | +44.8% | |
| – | -19.6% | +11.7% | +1.2% | +18.5% | +17.4% | +11.3% | +24.6% | +33.0% | +11.6% | +5.4% | +10.8% | |
| – | +9.8% | -62.7% | -979.3% | – | -49.7% | +804.7% | -63.2% | +543.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -2.6% | -1.7% | -13.0% | +28.5% | +21.6% | -35.1% | +14.2% | +46.5% | -12.6% | -31.3% | +51.4% | |
| – | +17.8% | +992.0% | -89.1% | -43.2% | +2,248.5% | -96.5% | +9.0% | +1,578.5% | -92.0% | -34.7% | +60.2% | |
| – | +0.7% | +0.5% | +0.4% | +0.6% | +0.7% | +1.0% | +1.9% | +3.0% | +2.3% | +0.6% | +0.4% | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | +8.1% | +694.0% | -105.5% | +150.9% | – | -108.5% | +183.1% | – | -125.9% | -18.2% | +3.6% | |
| – | -63.0% | – | -118.9% | +107.2% | – | -117.3% | +95.1% | – | -149.1% | +36.7% | -10.1% | |
| – | -48.1% | -830.3% | – | -390.9% | – | -82.0% | -533.9% | – | -157.4% | – | +9,935.6% | |
| – | -33.6% | -29.0% | +124.7% | +10.4% | +29.0% | -31.4% | +88.1% | -88.1% | +818.1% | +44.7% | -2.0% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.